Ozempic as an add-on to basal insulin and Ozempic 1 mg vs 2 mg SUSTAIN 5: add-on basal insulin 1,10 In patients with type 2 diabetes on basal insulin metformin Secondary endpoint: mean change in body weight from baseline to Week 30 Mean baseline: 202 lb SUSTAIN FORTE: Ozempic 1 mg vs 2 mg 1,4,8 In patients with type 2 diabetes on metformin sulfonylurea Secondary endpoint: mean change in body weight from baseline to Week 40 Mean baseline: 219 lb Results based on sensitivity analyses of retrieved dropout population
Consumer Review Studies: Non-clinical research combining consumer feedback, sensory evaluation, and functional satisfaction to guide the development of GLP-1 products and improve acceptance, usability, and perceived benefits
Addressing concerns about online data privacy with large language models
1 Their high target specificity and often favourable safety profiles combine with structural flexibility, enabling a broad range of chemical modifications that further reinforce peptides potential for treating a wide variety of complex diseases
Every production lot is independently assayed by an accredited third-party analytical laboratory using reverse-phase HPLC and electrospray-ionization mass spectrometry